Research ArticleAccepted Article
Do serum urate-associated genetic variants influence gout risk in people on diuretics? Analysis of the UK Biobank
Ravi K. Narang, Greg Gamble, Amanda J. Phipps-Green, Ruth Topless, Murray Cadzow, Lisa K. Stamp, Tony R. Merriman and Nicola Dalbeth
The Journal of Rheumatology February 2020, jrheum.191005; DOI: https://doi.org/10.3899/jrheum.191005
Ravi K. Narang
Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Rd, Grafton, Auckland, New Zealand. This work was supported by the Health Research Council of New Zealand (grant number 14-527). Conflict of interest: TRM has received consulting fees or grants from Ardea Biosciences and AstraZeneca. ND has received consulting fees, speaker fees or grants from AstraZeneca, Dyve Bio, Hengrui, Pfizer, Jannsen, Abbvie, and Horizon. None of the other authors have competing interests. Corresponding author: Prof Nicola Dalbeth, Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Rd, Grafton, Auckland, New Zealand. Email: n.dalbeth@auckland.ac.nz.
Greg Gamble
Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Rd, Grafton, Auckland, New Zealand. This work was supported by the Health Research Council of New Zealand (grant number 14-527). Conflict of interest: TRM has received consulting fees or grants from Ardea Biosciences and AstraZeneca. ND has received consulting fees, speaker fees or grants from AstraZeneca, Dyve Bio, Hengrui, Pfizer, Jannsen, Abbvie, and Horizon. None of the other authors have competing interests. Corresponding author: Prof Nicola Dalbeth, Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Rd, Grafton, Auckland, New Zealand. Email: n.dalbeth@auckland.ac.nz.
Amanda J. Phipps-Green
Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Rd, Grafton, Auckland, New Zealand. This work was supported by the Health Research Council of New Zealand (grant number 14-527). Conflict of interest: TRM has received consulting fees or grants from Ardea Biosciences and AstraZeneca. ND has received consulting fees, speaker fees or grants from AstraZeneca, Dyve Bio, Hengrui, Pfizer, Jannsen, Abbvie, and Horizon. None of the other authors have competing interests. Corresponding author: Prof Nicola Dalbeth, Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Rd, Grafton, Auckland, New Zealand. Email: n.dalbeth@auckland.ac.nz.
Ruth Topless
Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Rd, Grafton, Auckland, New Zealand. This work was supported by the Health Research Council of New Zealand (grant number 14-527). Conflict of interest: TRM has received consulting fees or grants from Ardea Biosciences and AstraZeneca. ND has received consulting fees, speaker fees or grants from AstraZeneca, Dyve Bio, Hengrui, Pfizer, Jannsen, Abbvie, and Horizon. None of the other authors have competing interests. Corresponding author: Prof Nicola Dalbeth, Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Rd, Grafton, Auckland, New Zealand. Email: n.dalbeth@auckland.ac.nz.
Murray Cadzow
Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Rd, Grafton, Auckland, New Zealand. This work was supported by the Health Research Council of New Zealand (grant number 14-527). Conflict of interest: TRM has received consulting fees or grants from Ardea Biosciences and AstraZeneca. ND has received consulting fees, speaker fees or grants from AstraZeneca, Dyve Bio, Hengrui, Pfizer, Jannsen, Abbvie, and Horizon. None of the other authors have competing interests. Corresponding author: Prof Nicola Dalbeth, Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Rd, Grafton, Auckland, New Zealand. Email: n.dalbeth@auckland.ac.nz.
Lisa K. Stamp
Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Rd, Grafton, Auckland, New Zealand. This work was supported by the Health Research Council of New Zealand (grant number 14-527). Conflict of interest: TRM has received consulting fees or grants from Ardea Biosciences and AstraZeneca. ND has received consulting fees, speaker fees or grants from AstraZeneca, Dyve Bio, Hengrui, Pfizer, Jannsen, Abbvie, and Horizon. None of the other authors have competing interests. Corresponding author: Prof Nicola Dalbeth, Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Rd, Grafton, Auckland, New Zealand. Email: n.dalbeth@auckland.ac.nz.
Tony R. Merriman
Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Rd, Grafton, Auckland, New Zealand. This work was supported by the Health Research Council of New Zealand (grant number 14-527). Conflict of interest: TRM has received consulting fees or grants from Ardea Biosciences and AstraZeneca. ND has received consulting fees, speaker fees or grants from AstraZeneca, Dyve Bio, Hengrui, Pfizer, Jannsen, Abbvie, and Horizon. None of the other authors have competing interests. Corresponding author: Prof Nicola Dalbeth, Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Rd, Grafton, Auckland, New Zealand. Email: n.dalbeth@auckland.ac.nz.
Nicola Dalbeth
Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Rd, Grafton, Auckland, New Zealand. This work was supported by the Health Research Council of New Zealand (grant number 14-527). Conflict of interest: TRM has received consulting fees or grants from Ardea Biosciences and AstraZeneca. ND has received consulting fees, speaker fees or grants from AstraZeneca, Dyve Bio, Hengrui, Pfizer, Jannsen, Abbvie, and Horizon. None of the other authors have competing interests. Corresponding author: Prof Nicola Dalbeth, Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Rd, Grafton, Auckland, New Zealand. Email: n.dalbeth@auckland.ac.nz.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Accepted manuscript
Do serum urate-associated genetic variants influence gout risk in people on diuretics? Analysis of the UK Biobank
Ravi K. Narang, Greg Gamble, Amanda J. Phipps-Green, Ruth Topless, Murray Cadzow, Lisa K. Stamp, Tony R. Merriman, Nicola Dalbeth
The Journal of Rheumatology Feb 2020, jrheum.191005; DOI: 10.3899/jrheum.191005
Accepted manuscript
Do serum urate-associated genetic variants influence gout risk in people on diuretics? Analysis of the UK Biobank
Ravi K. Narang, Greg Gamble, Amanda J. Phipps-Green, Ruth Topless, Murray Cadzow, Lisa K. Stamp, Tony R. Merriman, Nicola Dalbeth
The Journal of Rheumatology Feb 2020, jrheum.191005; DOI: 10.3899/jrheum.191005